Related Experiment Video
Updated: Jun 10, 2026
04:58
Collecting And Measuring Wound Exudate Biochemical Mediators In Surgical Wounds
Published on: October 20, 2012
Interleukin-6 levels in tension headache patients
Abdulkadir Koçer1, Emel Koçer, Ramazan Memişoğullari
1Department of Neurology, Düzce University Medical Faculty, Turkey. abdulkadirkocer@yahoo.com
The Clinical Journal of Pain
|July 29, 2010
Summary
Interleukin 6 (IL-6) levels were higher in tension-type headache (TTH) patients compared to controls, suggesting a role for IL-6 in TTH pathogenesis and inflammation. Further research is needed on cytokine levels and headache chronicity.
Area of Science:
- Neuroscience
- Immunology
- Pain Medicine
Background:
- Cytokines, such as interleukin 6 (IL-6), are implicated as pain mediators in neurovascular inflammation.
- Understanding the role of specific cytokines in headache disorders is crucial for elucidating their pathogenesis.
Purpose of the Study:
- To investigate serum interleukin 6 (IL-6) levels in patients with tension-type headache (TTH).
- To determine if elevated IL-6 levels indicate inflammation's involvement in the development of TTH.
Main Methods:
- Serum IL-6 levels were measured in 42 TTH patients and 37 healthy controls.
- TTH patients were categorized into episodic TTH (ETTH) and chronic TTH (CTTH) groups based on headache frequency.
Main Results:
- Serum IL-6 levels were significantly elevated in TTH patients compared to healthy controls (P<0.01 for CTTH).
- IL-6 levels were higher in chronic TTH patients than in controls, but similar between ETTH and CTTH groups.
- A positive correlation was observed between patient age and serum IL-6 levels.
Conclusions:
- Both chronic and episodic TTH patients exhibit higher serum IL-6 levels than controls.
- IL-6 may contribute to pain induction or inflammatory processes underlying TTH.
- Further investigation is warranted to explore the relationship between headache chronicity and cytokine levels.
Related Concept Videos
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...